NCT00140439 is IMPACT DC, a randomized trial of an emergency-department-based follow-up clinic for children with high asthma morbidity. Teach and colleagues randomized 488 children aged 1–17, 244 per group, to a comprehensive clinic visit or an educational booklet/control condition. The visit addressed self-management, environmental triggers and links to ongoing care. 12

172 of 244 intervention patients (70.5%) attended. Over six months, adjusted mean unscheduled asthma visits were 1.39 with intervention versus 2.34 with control; relative risk 0.60, 95% CI 0.46–0.77. This is direct evidence of reduced unscheduled use, not merely a planned endpoint. 2

At six months, reported inhaled-corticosteroid use in the preceding two days was 49.3% versus 26.5%, and selected quality-of-life measures also favored intervention. The result concerns a bundled follow-up service in this high-morbidity urban population; it does not isolate which component caused the improvement or demonstrate the same effect in every healthcare setting. 2